Close

Unusual 11 Mid-Day Movers 11/01: AVNR, XCO, KSP, NTE, VTRO, SUR Higher; WL, BIOD, ANPI, ABK, CDII Lower

November 1, 2010 1:54 PM EDT Send to a Friend
Avanir Pharmaceuticals (Nasdaq: AVNR) 110.7% HIGHER; received FDA approval for NUEDEXTA as the first treatment for pseudobulbar affect. Pseudobulbar affect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login